Pharmafile Logo

Peter Impey

- PMLiVE

Nektar hit by breast cancer trial setback

NKTR-102 failed to meet phase III targets

- PMLiVE

Sanofi on track to refile Lyxumia in US

Study showed drug was equivalent to placebo in cardiovascular safety

NDA Group names general manager of new Switzerland operation

Stephanie Krumholz-Bahner has held numerous senior roles

- PMLiVE

Actavis completes $70.5bn Allergan acquisition

Finalisation comes after bidding war with deal-hungry Valeant

Anticipating the future in healthcare

New technologies will be key drivers for change

- PMLiVE

Driving lasting collaborations

Whyin-group psychology can help

UK flag

Pharmacists to help England’s GPs manage patients, medicines

Comes as doctor groups fear that primary care is struggling under increasing workloads

- PMLiVE

GSK and Lilly invest in $100m global Dementia Discovery Fund

Fund announced at WHO conference by UK health secretary Jeremy Hunt

New hire at Eurocom Healthcare Communications

New account manager Yasmin Knox will work on key healthcare brand accounts

- PMLiVE

Valeant raises offer for Salix; rival Endo bows out

Has increased bid to $173 per share in cash

- PMLiVE

AstraZeneca scores in final lung disease drug trials

The firm hopes it LAMA/LABA drug can take a big chunk from the $14bn COPD market

- PMLiVE

Catalent promotes Sharon Johnson within new organisation

She will be its senior VP of global quality and regulatory affairs

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links